Jim McVeigh (@m075841)
Activity by Jim McVeigh
Phoenix, AZ — Concussions are in the national spotlight for the damage being done to student and professional athletes. Determining when an athlete should be removed from play is a major challenge in preventing injury. Athletes routinely deny symptoms.
The Centers for Disease Control and Prevention estimates that between 1.6 and 3.8 million students have concussions every year. In an effort to bring awareness and increase concussion screening, Mayo Clinic has agreed to a licensing agreement with King-Devick Test Inc., which has developed a proven indicator of ocular motor, visual and cognitive function for concussion detection and evaluation on the sidelines of sporting events to help with the decision to sideline athletes to prevent injury.
Under the terms of the agreement, the King-Devick Concussion Screening Test will be formally recognized as the King-Devick Test In Association With Mayo Clinic. The King-Devick Test is a quick, accurate and objective concussion screening tool that can be administered on the sidelines by parents, coaches, athletic trainers, school nurses and medical professionals.
WHAT: Audio news conference about an agreement between Mayo Clinic and King-Devick to bring an objective
concussion screening tool that can be administered on the sidelines by parents, coaches, athletic trainers, school nurses and medical professionals.
WHO: Mayo Clinic and King-Devick
David Dodick, M.D., Mayo Clinic Neurologist, Director, Mayo Clinic Concussion Program
Steve Devick, founder and developer of the King-Devick Test
WHEN: Tuesday, Jan. 27 8:30 a.m. (MST)
CALL-IN: Journalists can join the call at: 800-768-2481.
RSVP: Emily Blahnik at email@example.com or 507-538-7404.
INFO: Journalists who are registered members of Mayo Clinic News Network will have access to materials under embargo at http://newsnetwork.mayoclinic.org/. Journalists can register at http://newsnetwork.mayoclinic.org/request-account/. [...]
PHOENIX — A smell test could someday be one of the tools to screen for people at risk of developing Parkinson’s disease, according to a new Mayo Clinic study.
Parkinson's disease is a progressive disorder of the nervous system that affects movement. It develops gradually, sometimes starting with a barely noticeable tremor in just one hand. But while tremor may be the best-known sign of Parkinson's, the disorder also commonly causes stiffness and slowing of movement. Additionally, there are many non-movement problems, including constipation, loss of the sense of smell, sleep problems, lightheadedness, urinary difficulties, depression and anxiety. The non-movement symptoms can develop many years before movement disorders.
Although Parkinson's disease can't be cured, medications may markedly improve symptoms. Currently, there is no accurate diagnostic test for the disease; diagnosis is based on medical history, a review of signs and symptoms, a neurological and physical examination and by ruling out other conditions. Confirmation of the disease can only be made by performing an autopsy. [...]
PHOENIX — Researchers from Mayo Clinic in Arizona and Banner Sun Health Research Institute have determined that many people with an early diagnosis of Parkinson’s disease are not correctly diagnosed according to a study just published in the journal Neurology.
Parkinson's disease is a progressive disorder of the nervous system that affects movement. It develops gradually, sometimes starting with a barely noticeable tremor in just one hand. But while tremor may be the best-known sign of Parkinson's, the disorder also commonly causes stiffness and slowing of movement. Additionally there are many non-movement problems including constipation, loss of the sense of smell, sleep problems, lightheadedness, urinary difficulties, depression and anxiety. Although Parkinson's disease can't be cured, medications may markedly improve symptoms. Currently, there is no accurate diagnostic test for the disease; diagnosis is made based on medical history, a review of signs and symptoms, a neurological and physical examination and by ruling out other conditions. Confirmation of the disease can only be made by performing an autopsy.
PHOENIX, Arizona – The National Institutes of Health (NIH) renewed funding for the Banner Alzheimer’s Institute (BAI) and Mayo Clinic, Phoenix, longitudinal study of the earliest changes associated with the risk of developing Alzheimer’s disease at older ages. The award, an estimated $8.3 million over the next five years, continues NIH’s long-term support of the investigation.
The study, which began two decades ago, has been examining the subtle brain imaging, memory and thinking changes that occur in healthy late-middle-aged and older adults who have inherited from their parents either one, two or no copies of the apolipoprotein E (APOE4) gene, the major genetic risk factor for developing late-onset Alzheimer’s. Each additional copy of the gene significantly increases a person’s chance of developing the disease.
“We are extremely grateful to the NIH and our wonderful research volunteers for their support,” said Dr. Eric M. Reiman, BAI Executive Director and one of the study’s principal investigators. “From the beginning, this study has been driven by our interest in finding treatments to prevent or end Alzheimer’s as quickly as possible, and to provide the information and tools needed to do just that.” [...]
SCOTTSDALE, Ariz. – The use of small, portable eye-tracking devices in cockpits could be a future additional safeguard for pilots and other safety critical operators, according to a Mayo Clinic study published in the July issue of Aviation, Space and Environmental Medicine.
Eye movement metrics have been recognized as promising indicators of altered cognitive performance caused by hypoxia at high altitudes. Hypoxia is a lower than normal level of oxygen in your blood. To function properly, your body needs a certain level of oxygen circulating in the blood to cells and tissues. When this level of oxygen falls below a certain amount, hypoxia can cause a variety of symptoms including shortness of breath, impaired speech, slowed reaction time and passing out which can be a safety threat at high altitudes.
PHOENIX — A new Mayo Clinic study suggests that the care and support family members give to elderly widows following the death of their spouse may be a factor in delaying dementia.
The study presented at the Alzheimer’s Association International Conference in Copenhagen, Denmark last week was designed to evaluate the effects of widowhood in people with mild cognitive impairment - a precursor of dementia. The thinking had been that widowhood would accelerate the development of dementia in people with MCI but the study showed the opposite.
Mayo Clinic researchers used data on more than 3,500 people from the National Alzheimer’s Coordinating Center database, which compiles information collected at various Alzheimer’s disease Centers in the U.S. The researchers found that of the 1,078 subjects who developed dementia, people who remained married developed dementia at a younger age than those who were widowed (83 years old versus 92 years).
Mayo Clinic also earned the No. 1 overall spot on the “Best Hospitals” list
PHOENIX — Mayo Clinic Hospital in Phoenix is ranked No. 1 in Arizona and the Phoenix metro area in the 25th U.S. News & World Report annual America’s Best Hospital List released today.
Hospitals included in the U.S. News Report such as the Mayo Clinic, are part of an elite group recognized for “breadth of excellence,” according to the magazine. Mayo Clinic in Arizona ranked nationally in 10 specialties including cancer, cardiology and heart surgery, ear, nose & throat, gastroenterology & GI surgery, geriatrics, gynecology, nephrology, neurology and neurosurgery, orthopedics and urology. In addition, Mayo Clinic in Arizona is recognized as high performing in diabetes and endocrinology.
Page loaded in 0.650 seconds